Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon
artificial intelligence AI heart cardiology

Cleerly’s AI software for noninvasive FFR estimates receives a Category 1 CPT code

The company officially launched its Cleerly ISCHEMIA software for delivering noninvasive evaluations of CCTA exams in early 2024. This update provides a closer look at the software from a billing perspective. 

Melissa Chen, MD, Clinical Neuroradiologist, Associate Professor, University of Texas MD Anderson Cancer Center, said challenges ton radiology include the limitations of the relative value units (RVUs) used to pay radiologists, the need for balancing workloads despite disincentives to reading some studies, and the need to find new workflow efficiencies with AI to offset the radiologist shortage. #RSNA

Radiology at tipping point with limitations of RVUs and the growing shortage of radiologists

Melissa Chen, MD, MD Anderson Cancer Center, outlines some of the challenges practices are facing and possible solutions.

Richard Heller, MD, RSNA Board member, associate chief medical officer for health policy and communications, and national director of pediatric radiology at Radiology Partners, explains some insurance companies are trying to take advantage of the No Surprises Billing Act by telling radiology practices they need to accept lower rates to remain part of the providers in-network.

Radiologists urged to report insurance companies forcing lower reimbursements due to No Surprises Act

Some payers are taking advantage of the NSA by forcing practices to accept lower rates to remain in-network, says Rad Partners' Richard Heller, MD. 

ovaries ovarian cancer

Lab receives $30M funding to illuminate lung and ovarian cancers

On Target Laboratories will use the funding to expand the market reach of its molecular imaging agent.

Video of Geraldine McGinty, MD, MBA, Senior Associate Dean for Clinical Affairs, Professor of Clinical Radiology and Population Health Sciences, Weill Cornell Medicine, offering tips to retain radiologists. #greatresignation #ACR #RSNA #radiology

Improving recruitment and retention in radiology

Geraldine McGinty, MD, Weill Cornell Medicine, explains how practices can retain radiologists during the Great Resignation in healthcare.

Peter Moffatt, RBMA president-elect, discusses biggest issues facing radiology practices at RSNA 2023. #RBMA #RSNA #Radiology #CMScuts

Navigating the crucial challenges in radiology practice management

RBMA President-elect Pete Moffatt discusses how to contend with challenges such as staff shortages and reimbursement issues.

Video interview with Richard Heller, MD, RSNA Board member, associate chief medical officer for health policy and communications, and national director of pediatric radiology at Radiology Partners, explains the impact of the 2024 Medicare cuts on radiology and what comes next. #RSNA #RSNZA23 #RSNA2023 #CMS #Radiology

Putting US radiology reimbursement cuts in context and what comes next

Richard Heller, MD, a member of the RSNA Board and associate CMO for Rad Partners, explains the impact of the 2024 Medicare cuts and what is at stake.

OU Health establishes Health Sciences Imaging Institute for training, research

Siemens Healthineers is providing technology for the new endeavor as part of a 10-year agreement.

Displaying 17 - 24 of 537

Around the web

Cardiovascular Business
A closer look at how FDA's flurpiridaz approval will impact nuclear cardiology

The newly approved PET radiotracer is expected to improve patient care significantly. “We have been able to reach the pinnacle of myocardial perfusion imaging with flurpiridaz," one expert said.

Cardiovascular Business
'This could be a paradigm shift': How PET with newly approved flurpiridaz compares to SPECT

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Cardiovascular Business
Ultrafast myocardial contrast echocardiography shows early potential to evaluate CAD

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Design by Adaptive Theme
Trimed Popup
Trimed Popup